Many supplements are available to the general public for a limited time on our SuppleNet page.
VOLUME 59 1998 SUPPLEMENT 14
Articles
3 Introduction. Reboxetine: A New Selective Antidepressant
for the Treatment of Depression. Stuart A. Montgomery, M.D., and Alan F. Schatzberg, M.D.
[PDF]
4 Antidepressant Efficacy and Tolerability of the
Selective Norepinephrine Reuptake Inhibitor Reboxetine:
A Review. Graham D. Burrows, M.D.; Kay P. Maguire, Ph.D.;
and Trevor R. Norman, Ph.D.
[Abstract]
[PDF]
8 Reboxetine Versus Fluoxetine:
An Overview of Efficacy and Tolerability. Juan Massana, M.D.
[Abstract]
[PDF]
11 Monoamine Dysfunction and the
Pathophysiology and Treatment of Depression. Dennis S. Charney, M.D.
[Abstract]
[PDF]
15 Noradrenergic Versus Serotonergic Antidepressants:
Predictors of Treatment Response. Alan F. Schatzberg, M.D.
[Abstract]
[PDF]
19 The Measurement of Retardation in Depression. Nicolas Dantchev, M.D., Ph.D., and Daniel J. Widlöcher, M.D.
[Abstract]
[PDF]
26 Chairman’s Overview:
The Place of Reboxetine in Antidepressant Therapy. Stuart A. Montgomery, M.D.
[PDF]